Skip to main content
. 2007 Mar 13;403(Pt 1):109–118. doi: 10.1042/BJ20061328

Table 2. Metabolism of AA by recombinant Cyp4a enzymes.

n.d., Not determined.

Km (μM) Vmax (nmol·nmol−1·min−1) Product distribution (%)*
CYP + cytb5 + cytb5 18-HETE 19-HETE 20-HETE 11,12-EET
4a10 n.d. n.d. 0.02±0.01 0.05±0.01 20 80
4a12a 25±4 34±6 8±1 16±2 13 87
4a12b 43±12 72±10 10±2 19±2 12 10 78
4a14 n.d. n.d. 0.01±0.003 0.01±0.001 100

*The metabolites were resolved and quantified by RP- and NP-HPLC as shown in Supplementary Figure S2. The values are averages for experiments with at least three different microsomal preparations. The standard errors were less than 10% of the mean.

†Activities of Cyp4a10 and Cyp4a14 are given for a substrate concentration of 10 μM since a detailed kinetic analysis was not possible due to the very weak activities of these isoforms towards AA. For comparison, under the same conditions, the corresponding values for Cyp4a12a were 2.3 and 3.7 (+cytb5) nmol·nmol−1·min−1 and for Cyp4a12b 1.9 and 2.3 (+cytb5) nmol·nmol−1·min−1.

‡Roughly estimated from RP-HPLC analysis.

HHS Vulnerability Disclosure